We are live on !
Find out more
HighMark Wealth Management Portfolio holdings
AUM
$299M
Turnover
13.67%
1-Year Est. Return
53.01%
This Fund
S&P 500
This Quarter Est. Return
+21.77%
1 Year Est. Return
+53.01%
3 Year Est. Return
+109.68%
5 Year Est. Return
+113.63%
10 Year Est. Return
–
AUM
$299M
AUM Growth
+$52.9M
(+22%)
Cap. Flow
+$8.26M
Cap. Flow % of AUM
Cap. Flow %
2.77%
Top 10 Holdings %
Top 10 Hldgs %
65.82%
Holding
600
New
46
Increased
156
Reduced
94
Closed
36
Avg Time Held
Equity + Options
3.4
years
Top 10 Avg Time Held
Equity + Options
2.7
years
Top 20 Avg Time Held
Equity + Options
2.3
years
Avg Time Held Equity only
3.4
years
Top 10 Avg Time Held Equity only
2.7
years
Top 20 Avg Time Held Equity only
2.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fidelity MSCI Health Care Index ETF
FHLC
|
+$18.3M |
| 2 |
SI-BONE Inc
SIBN
|
+$3.79M |
| 3 |
Duos Technologies
DUOT
|
+$2.91M |
| 4 |
Apogee Therapeutics
APGE
|
+$2.91M |
| 5 |
Neuropace
NPCE
|
+$1.61M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CNTA
Centessa Pharmaceuticals
CNTA
|
+$9.41M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$5.14M |
| 3 |
AnaptysBio
ANAB
|
+$3.29M |
| 4 |
iShares MSCI EAFE Value ETF
EFV
|
+$1.64M |
| 5 |
Piper Sandler
PIPR
|
+$1.27M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 64.9% |
| 2 | Healthcare | 21.84% |
| 3 | Technology | 4.77% |
| 4 | Financials | 3.58% |
| 5 | Industrials | 1.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
426
Leidos
LDOS
$18.1B
| $3.6K | ﹤0.01% |
35
| – | – |
2024 Q4
6 quarters
|
|
427
Voya Financial
VOYA
$9.01B
| $3.44K | ﹤0.01% |
+38
| New | +$3.1K |
2026 Q2
0 quarters
|
|
428
Iris Energy
IREN
$8.68B
| $3.43K | ﹤0.01% |
75
| – | – |
2025 Q4
2 quarters
|
|
429
Tilray
TLRY
$377M
| $3.35K | ﹤0.01% |
747
| – | – |
2024 Q1
9 quarters
|
|
430
State Street SPDR Nuveen ICE Short Term Municipal Bond ETF
SHM
$3.5B
| $3.3K | ﹤0.01% |
69
+1
| +1% | +$48 |
2025 Q2
4 quarters
|
|
431
Cameco
CCJ
$32B
| $3.26K | ﹤0.01% |
32
+10
| +45% | +$1.12K |
2025 Q4
2 quarters
|
|
432
Prudential
PUK
$30.6B
| $3.16K | ﹤0.01% |
118
-168
| -59% | -$4.91K |
2019 Q4
26 quarters
|
|
433
Qnity Electronics Inc
Q
$24.1B
| $3.11K | ﹤0.01% |
19
| – | – |
2025 Q4
2 quarters
|
|
434
RELX
RELX
$70.2B
| $3.06K | ﹤0.01% |
97
+19
| +24% | +$644 |
2019 Q4
26 quarters
|
|
435
Royal Gold
RGLD
$20B
| $3.02K | ﹤0.01% |
15
-2
| -12% | -$465 |
2025 Q2
4 quarters
|
|
436
Barclays
BCS
$75.2B
| $2.96K | ﹤0.01% |
110
-83
| -43% | -$2K |
2024 Q2
8 quarters
|
|
437
Toyota
TM
$231B
| $2.96K | ﹤0.01% |
18
-1
| -5% | -$189 |
2024 Q4
6 quarters
|
|
438
Alcoa
AA
$10.5B
| $2.92K | ﹤0.01% |
56
| – | – |
2023 Q2
12 quarters
|
|
439
Defiance Drone and Modern Warfare ETF
JEDI
$136M
| $2.9K | ﹤0.01% |
100
-100
| -50% | -$3.08K |
2026 Q1
1 quarter
|
|
440
Invesco China Technology ETF
CQQQ
$1.81B
| $2.85K | ﹤0.01% |
+50
| New | +$2.58K |
2026 Q2
0 quarters
|
|
441
KKR & Co
KKR
$88B
| $2.78K | ﹤0.01% |
30
| – | – |
2024 Q4
6 quarters
|
|
442
Transmedics
TMDX
$2.31B
| $2.72K | ﹤0.01% |
41
| – | – |
2023 Q2
12 quarters
|
|
443
Immersion
IMMR
$235M
| $2.7K | ﹤0.01% |
400
+5
| +1% | +$32 |
2023 Q2
12 quarters
|
|
444
STMicroelectronics
STM
$42.2B
| $2.7K | ﹤0.01% |
+36
| New | +$2.16K |
2026 Q2
0 quarters
|
|
445
Cadence Design Systems
CDNS
$90.4B
| $2.63K | ﹤0.01% |
7
| – | – |
2020 Q4
22 quarters
|
|
446
Zimmer Biomet
ZBH
$18.6B
| $2.58K | ﹤0.01% |
+30
| New | +$2.63K |
2026 Q2
0 quarters
|
|
447
GE HealthCare
GEHC
$36B
| $2.57K | ﹤0.01% |
40
| – | – |
2023 Q1
13 quarters
|
|
448
VanEck Intermediate Muni ETF
ITM
$2.3B
| $2.56K | ﹤0.01% |
55
+1
| +2% | +$47 |
2025 Q2
4 quarters
|
|
449
Ouster
OUST
$2.04B
| $2.56K | ﹤0.01% |
41
| – | – |
2025 Q2
4 quarters
|
|
450
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$45.2B
| $2.43K | ﹤0.01% |
5
| – | – |
2024 Q4
6 quarters
|
|
Similar funds
BOC
HighMark Wealth Management's Q2 2026 Portfolio in Review
As of Q2 2026, HighMark Wealth Management held 600 positions worth $299M, up 22% from $246M the previous quarter. Its ten largest holdings account for 66% of the portfolio.
HighMark Wealth Management's Q2 2026 filing shows 46 new, 156 increased, 94 reduced and 36 closed positions. Its largest new stake was Duos Technologies: 289,884 shares worth $3.48M. The largest sale was Centessa Pharmaceuticals, an estimated $9.41M.
By sector, the portfolio is most concentrated in Miscellaneous at 65% of assets, down from 65% a quarter earlier, followed by Healthcare and Technology.
- HighMark Wealth Management's largest Q2 2026 buy was Duos Technologies: 289,884 shares worth $3.48M.
- HighMark Wealth Management added most to Fidelity MSCI Health Care Index ETF in Q2 2026, an estimated $18.3M increase.
- HighMark Wealth Management's biggest Q2 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $5.14M.
- HighMark Wealth Management fully exited Centessa Pharmaceuticals in Q2 2026, selling an estimated $9.41M.
- HighMark Wealth Management's ten largest holdings make up 66% of its $299M portfolio in Q2 2026.
- HighMark Wealth Management opened 46 new positions and closed 36 in Q2 2026.
- HighMark Wealth Management's portfolio value rose 22% quarter-over-quarter to $299M.
Based on HighMark Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.